Liver stiffness not steatotic liver disease is associated with atrial fibrillation
What should I do for an older patient who is referred for liver fibrosis but does not appear to have any clear liver disease?
Steatotic-What? Changes in Fatty Liver Nomenclature
MASLD Metabolic dysfunction-associated steatotic liver disease (MASLD) refers to the presence of hepatic steatosis when no other causes for secondary hepatic fat accumulation are present, and patients...
A Stiff Competition: Comparing the MEFIB Index and FAST Score for the Detection of Fibrosis in MASLD
If I want to diagnose advanced fibrosis in my patient, how much better is MRI with FIB-4 compared to Fibroscan with AST?
Obeticholic Acid for the Treatment of Non-alcoholic Steatohepatitis
Now that the FDA has rejected obeticholic acid for NASH, what WAS the evidence supporting its use?
What's New in NASH with Mary Rinella
Podcast URL Show Notes There are new NASH Guidelines and we're gonna talk about them. Who better to chat with than lead author Dr. Mary Rinella? Probably nobody! But first, the precarities of being an...
Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease?
GLP-1 agonists are approved for the treatment of diabetes and for obesity. Why are patients with non-alcoholic fatty liver disease (NAFLD) suddenly being prescribed GLP-1 agonists and what are the...
Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis
Does weight loss really help with managing NASH?
Can Diabetic Medications and Glycemic Control Affect the Incidence of HCC in Patients with NAFLD?
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.32244 More benefits of good glycemic control in patients with NAFLD!
Medical Therapy for NASH: The PIVENS Trial
Are there any treatment options for medical management of NASH? Find out in this summary of the PIVENS Trial!